MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$2.20 USD
-0.28 (-11.29%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $2.21 +0.01 (0.45%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for MAIA Biotechnology, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 0 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 20 | 16 | 8 | 0 | 0 |
Income After Depreciation & Amortization | -20 | -16 | -8 | 0 | 0 |
Non-Operating Income | 0 | 0 | -4 | NA | NA |
Interest Expense | 0 | 0 | 1 | NA | NA |
Pretax Income | -20 | -16 | -13 | NA | NA |
Income Taxes | 0 | 0 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -20 | -16 | -13 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -20 | -16 | -13 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -20 | -16 | -7 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | NA | NA |
Income After Depreciation & Amortization | -20 | -16 | -8 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 13.26 | 9.28 | 5.28 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.49 | -1.75 | -2.37 | NA | NA |
Diluted Net EPS (GAAP) | -1.49 | -1.75 | -2.37 | NA | NA |
Fiscal Year end for MAIA Biotechnology, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 6.38 | 4.96 | 4.67 | 4.19 | 4.19 |
Income After SG&A, R&D, and Dept/Amort Expenses | -6.38 | -4.96 | -4.67 | -4.19 | -4.19 |
Non-Operating Income | 0.12 | 0.08 | 0.14 | 0.07 | 0.18 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Pretax Income | -6.26 | -4.88 | -4.52 | -4.12 | -5.12 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.26 | -4.88 | -4.52 | -4.12 | -4.67 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.26 | -4.88 | -4.52 | -4.12 | -4.67 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 13.26 | 13.68 | 12.89 | 10.98 | 9.28 |
Diluted EPS Before Non-Recurring Items | -0.41 | -0.36 | -0.35 | -0.38 | -0.35 |
Diluted Net EPS (GAAP) | -0.40 | -0.36 | -0.35 | -0.38 | -0.36 |